bioRxiv Science⌕ Search

Biology subjects

Delbono, O.

Publications and source records attributed to Delbono, O..

2 recordsLinked to original sources

Spinal Noradrenergic Overdrive Promotes Reversible Motor Unit Aging and Sarcopenia

Background Sarcopenia is characterized by progressive loss of skeletal muscle mass, strength, and physical function with aging. Motor unit degeneration is a major contributor, but the mechanisms driving age-related deterioration of motor neurons, neuromuscular junctions (NMJs), and muscle fibers remain incompletely understood. Norepinephrine (NE) regulates spinal motor neuron excitability, but its role in motor unit aging has not been established. Methods Whole-cell patch-clamp electrophysiology, optogenetics, fast-scan cyclic voltammetry, microdialysis, high-performance liquid chromatography, western blotting, and chemogenetics were used in mice aged 1-25 months. Motor neuron intrinsic properties were examined in 135 lumbar motor neurons from 81 mice. NE release dynamics, tissue content, and expression of the NE transporter (NET) and 2A-adrenergic autoreceptor were assessed in adult and aged mice. Descending spinally projecting noradrenergic neurons were selectively inhibited in aged mice using a retrograde chemogenetic approach. Results Aging produced progressive motor neuron hyperexcitability characterized by membrane depolarization, increased input resistance, elevated firing frequency, and altered action potential threshold (all P < 0.005). Optogenetically evoked endogenous NE increased motor neuron excitability by reducing action potential latency (P = 0.0001) and decreasing rheobase (P = 0.0028); these effects were prevented by 1-adrenergic receptor blockade (P = 0.0313). Aging enhanced stimulus-evoked spinal NE release, with greater responses at 20 Hz (P = 0.0223), 30 Hz (P = 0.0022), and 40 Hz (P < 0.0001). NE release elicited by stimulation of locus coeruleus and A5 noradrenergic inputs was also increased in aged mice (P = 0.0349 and P = 0.0016, respectively). Basal extracellular NE concentrations were unchanged, whereas spinal cord NE content increased (P = 0.0403). Aging reduced 2A-adrenergic receptor (P = 0.0009) and NET expression (P = 0.0046). Chemogenetic suppression of descending noradrenergic neurons in aged mice increased hindlimb muscle mass (P = 0.0111-0.0344), muscle fiber cross-sectional area (P = 0.0078-0.0467), NMJ innervation (P = 0.0210), and motor neuron soma size (P = 0.0353). Conclusions Aging promotes spinal noradrenergic overdrive characterized by increased NE storage, enhanced activity-dependent NE release, and impaired autoregulatory control. Excessive noradrenergic signaling contributes to motor neuron hyperexcitability and motor unit deterioration. Suppression of descending noradrenergic activity reverses structural features of motor neuron, NMJ, and skeletal muscle aging, identifying spinal noradrenergic signaling as a potential therapeutic target for sarcopenia.

neuroscience↗

Mitochondria-containing large extracellular vesicles target mouse motor neurons upon intramuscular injection

Amyotrophic Lateral Sclerosis (ALS) is a neurological disorder that causes progressive degeneration of motor neurons. Mitochondrial dysfunction accelerates neurodegeneration aggravating the severity of ALS. We hypothesized that increasing the mitochondrial function of motor neurons may promote neuronal survival. Therefore, we investigated the potential of neuron-derived mitochondria containing extracellular vehicles (EVs) as a novel therapeutic approach for ALS using differentiated NSC-34 cells as a surrogate for neurons. Neuron derived-large EVs (lEVs) but not small EVs (sEVs) contained mitochondria. However, we observed increased cell viability and oxygen consumption rates in heat-stressed neurons treated with both sEVs and lEVs suggesting improved mitochondrial function in recipient neurons. The increased oxygen consumption rates in sEV-treated heat-stressed neurons was accompanied by a greater proton leak compared to lEV treatment. The greater proton leak observed with sEVs likely suggests a lower efficiency of oxidative phosphorylation compared to that achieved by cells treated with mitochondria-containing lEVs. These findings suggest that mitochondrial components present in sEVs, such as proteins and mitochondrial DNA, may too contribute to improving cellular respiration. Furthermore, we have demonstrated that lEV mitochondria are transported into the lumbar spinal cord motor neurons following intramuscular injection in C57BL/6 mice in a EV dose-dependent manner. Collectively, for the first time, we have demonstrated the therapeutic effects of neuronal EVs in recipient heat-stressed neurons and the delivery of lEV mitochondria to spinal cord motor neurons in vivo without any EV surface modifications for neuronal targeting. Further studies will determine the therapeutic efficacy of mitochondria-containing EVs in the SOD1G93A transgenic mouse model of ALS. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=166 HEIGHT=200 SRC="FIGDIR/small/675842v1_ufig1.gif" ALT="Figure 1"> View larger version (52K): org.highwire.dtl.DTLVardef@af590aorg.highwire.dtl.DTLVardef@1fed11dorg.highwire.dtl.DTLVardef@52d339org.highwire.dtl.DTLVardef@1a97182_HPS_FORMAT_FIGEXP M_FIG C_FIG

bioengineering↗